Aayerah Pharmaceuticals Private Limited
About Aayerah Pharmaceuticals Private Limited
Data last updated:
Aayerah Pharmaceuticals Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 15 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U85100OR2019PTC030264. Its GSTIN is 21AARCA7986K1ZZ (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Halima Sadeeya and Akbar Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 669 Sub Plot No – 25/8 Panchasakha Nagar Dumuduma, Bhubaneswar, Odisha, India – 751019.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.13 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹53,947 (net margin 2.1%) and EBITDA of ₹2.14 Lakh (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 290% over five years.
As per MCA filings, the company has open charges of ₹11 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No – 669 Sub Plot No – 25/8 Panchasakha Nagar Dumuduma, Bhubaneswar, Odisha, India – 751019
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aayerah Pharmaceuticals Private Limited
The main business activity of Aayerah Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aayerah Pharmaceuticals Private Limited FY 2025 filings available
Aayerah Pharmaceuticals Private Limited reported revenue of ₹25.13 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aayerah Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 290% over five years, including 8% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aayerah Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.14 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹53,947 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aayerah Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aayerah Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aayerah Pharmaceuticals Private Limited
Aayerah Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the FMCG industry (Personal Care and Skin Care, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reydil Natural Sciences Private Limited | ₹25.26 Lakh (FY 2025) | •••• | •••• | 23.0% | •••• | Kurukshetra, Haryana, India |
| Baiyoke Pharmaceuticals Private Limited | ₹25.25 Lakh (FY 2019) | •••• | •••• | 83.0% | •••• | Gwalior, Madhya Pradesh, India |
| Eldorex Pharmaceuticals Private Limited | ₹25.2 Lakh (FY 2025) | •••• | •••• | 149.0% | •••• | Thane, Maharashtra, India |
| Coix Pharmaceuticals Private Limited | ₹25.2 Lakh (FY 2024) | •••• | •••• | 93.0% | •••• | Jamshedpur, Jharkhand, India |
| Brukshell Drugs and Pharmaceuticals Private Limited | ₹25.16 Lakh (FY 2025) | •••• | •••• | 145.0% | •••• | Ahmedabad, Gujarat, India |
| Aayerah Pharmaceuticals Private Limited this company | ₹25.13 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Bhubaneswar, Odisha, India |
| Anum Pharmaceuticals Private Limited | ₹25.13 Lakh (FY 2024) | •••• | •••• | -33.0% | •••• | Nagpur, Maharashtra, India |
| Ameria Skinscience Private Limited | ₹25.06 Lakh (FY 2025) | •••• | •••• | 630.0% | •••• | Vadodara, Gujarat, India |
| Dekunes Pharmaceuticals Private Limited | ₹25.05 Lakh (FY 2024) | •••• | •••• | 11.0% | •••• | Noida, Uttar Pradesh, India |
| Galgoties Pharmaceuticals Private Limited | ₹24.9 Lakh (FY 2024) | •••• | •••• | 29.0% | •••• | Bhubanesware, Odisha, India |
| Vrisha Pharmaceuticals Private Limited | ₹24.87 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Navi Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Aayerah Pharmaceuticals by revenue in the FMCG industry (Personal Care and Skin Care, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Aayerah Pharmaceuticals Private Limited
Aayerah Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Halima Sadeeya Also directs: Aalarik Commodity Private Limited | Director | 15 Jan 2019 | 7 Years 9 Months | Current |
| Akbar Khan | Director | 11 Oct 2021 | 5 Years 0 Months | Current |
Ownership and Shareholding of Aayerah Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aayerah Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2025 | Others | ₹11 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Aayerah Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Aayerah Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aayerah Pharmaceuticals Private Limited
Aayerah Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Akbar Khan was appointed as Director on 11 Oct 2021.
Credit Ratings, Litigation & Regulatory Alerts for Aayerah Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aayerah Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aayerah Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aayerah Pharmaceuticals Private Limited
Aayerah Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AARCA7986K1ZZ | Odisha | Active | 13 Feb 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aayerah Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aayerah Pharmaceuticals Private Limited
Aayerah Pharmaceuticals is an active private limited company based in Bhubaneswar, Odisha, India. The company works in human health activities, within the healthcare industry. It was incorporated on 15 January 2019 (7+ years old) and is registered under CIN U85100OR2019PTC030264.
Aayerah Pharmaceuticals reported revenue of ₹25.13 Lakh for FY 2025 (up 8% YoY).
Aayerah Pharmaceuticals has 2 current directors:
- Halima Sadeeya - Director
- Akbar Khan - Director
Aayerah Pharmaceuticals reported a net profit of ₹53,947 (net margin 2.1%) and EBITDA of ₹2.14 Lakh (EBITDA margin 8.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aayerah Pharmaceuticals is 29% over three years and 290% over five years. In the latest year (FY 2025) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aayerah Pharmaceuticals is 21AARCA7986K1ZZ, registered in Odisha.
The CIN (Corporate Identification Number) of Aayerah Pharmaceuticals is U85100OR2019PTC030264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aayerah Pharmaceuticals was incorporated on 15 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Aayerah Pharmaceuticals by revenue are Reydil Natural Sciences Private Limited, Baiyoke Pharmaceuticals Private Limited, Eldorex Pharmaceuticals Private Limited, Coix Pharmaceuticals Private Limited, Brukshell Drugs and Pharmaceuticals Private Limited and 5 more, all in the FMCG industry (Personal Care and Skin Care, Pharmaceuticals).
Akbar Khan was appointed as Director on 11 Oct 2021. Debabrata Pattnaik ceased to be Director on 11 Oct 2021. Halima Sadeeya was appointed as Director on 15 Jan 2019.
The registered office of Aayerah Pharmaceuticals is at Plot No – 669 Sub Plot No – 258 Panchasakha Nagar Dumuduma, Bhubaneswar, Odisha, India – 751019.